Pan-cancer analysis highlights the role of PSENEN in the prognosis and immunology of cancer
Background: Presenilin enhancer-2 (PSENEN, PEN-2), one of the four components of the γ-secretase complex, has been increasingly revealed to be significant in cancer types such as pancreatic cancer, gastric cancer, and breast cancer. However, the pan-cancer clinical relevance of PSENEN remains unclea...
Saved in:
Main Authors: | Zerui YANG, Dingsheng WEN, Yubing YE, Kai CHEN, Zhikun QIU, Xingyun LIU, Xiong LI |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2023-03-01
|
Series: | Journal of Holistic Integrative Pharmacy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2707368823000973 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A pan-cancer analysis: predictive role of ZNF32 in cancer prognosis and immunotherapy response
by: Minghan Li, et al.
Published: (2025-01-01) -
Exploring SLC30A6 as a potential prognostic, immunomodulatory, and therapeutic biomarker in various cancers with a focus on pancreatic cancer: a pan-cancer analysis
by: Fatemeh Maghool, et al.
Published: (2024-11-01) -
Integrative pan-cancer analysis and experiment validation identified GLS as a biomarker in tumor progression, prognosis, immune microenvironment, and immunotherapy
by: Dongming Li, et al.
Published: (2025-01-01) -
Comprehensive pan-cancer analysis of CD73: Explore its association with prognosis and tumor immune microenvironment
by: Chen Chen, et al.
Published: (2024-11-01) -
PSENEN influences the progression of renal clear cell carcinoma by regulating the immune microenvironment and oxidative phosphorylation
by: Congying Huang, et al.
Published: (2024-11-01)